Skip to main navigation Skip to search Skip to main content

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

  • Tetsuhide Ito
  • , Takuji Okusaka
  • , Toshirou Nishida
  • , Kenji Yamao
  • , Hisato Igarashi
  • , Chigusa Morizane
  • , Shunsuke Kondo
  • , Nobumasa Mizuno
  • , Kazuo Hara
  • , Akira Sawaki
  • , Satoshi Hashigaki
  • , Nobuyuki Kimura
  • , Mami Murakami
  • , Emiko Ohki
  • , Richard C. Chao
  • , Masayuki Imamura

Research output: Contribution to journal › Article › peer-review

37   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases